Session
Speaker
Effect of One Low Molecular Weight Polysaccharide (LMW-ABP)
from Agaricus Blazei on Inhibiting Sialyl Lewis X/E-selectin-Mediated
Metastatic Potential in HT-29 Cells and Its Mechanism
Jicheng Liu, Yongxu Sun
China
To the best of our knowledge, the metastatic spread of tumor cells
is responsible for the majority of cancer patients' recurrence and
deaths. Suppressing, the metastasizing capacity of cancer cells has
been drawn more attentions by many research groups in realm of tumor
therapy research. This research shows that adhesion of circulating
tumor cells to vascular endothelium plays a crucial role in metastasis
formation. This adhesion was mainly interacted by E-selectin expressed
in activated endothelial cells and its ligand, sialyl Lewis X (sLex),
expressed on the surface of tumor cells. In our previous investigation,
one low molecular weight polysaccharide (LMW-ABP) of 4.8×104
Da was identified from the fruiting bodies of Agaricus blazei
which possesses very potent anti-tumor and anti-metastasis activities.
So in order to further investigate its molecular mechanisms of anti-metastasis.
We choose E-selectin and its ligand, sLex, as the research target.
Flow cytometry, real time-reverse transcription polymerase chain reaction
(RT-PCR) and other techniques are used in this study to investigate
whether LMW-ABP can inhibit neoplasm metastasis initiated by the adhesion
of HT-29 cells to human umbilical vein endothelial cells (HUVECs)
throuth suppressing the expression of FucT-VII in vitro.
First, cDNA of human FucT-VII is successfully cloned and inserted
into pIRS2-EGFP, eukaryote-expression vector, and FucT-VII RNA interence
system is also successfully constructed. Second, different concentrations
of LMW-ABP (5, 10, and 20 mg/L) could effectively dose-dependently
inhibit adhesion of HT-29 cells to HUVECs in static conditions, as
well as down-regulating the expression of both α 1-3 fucosyltransferase-VII
(FucT-VII) and sLex in transcription or translation level, respectively.
These results suggest that LMW-ABP could suppress the metastasizing
capacity of cancer cells through interfering with the interaction
between E-selectin and sLex. Thus based on these findings, LMW-ABP
is expected to be having enormou s potential for use in treatment
for neoplasm metastasis.
|